These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28359780)

  • 41. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
    McCartney CR; Eagleson CA; Marshall JC
    Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolism alteration in follicular niche: The nexus among intermediary metabolism, mitochondrial function, and classic polycystic ovary syndrome.
    Zhao H; Zhao Y; Li T; Li M; Li J; Li R; Liu P; Yu Y; Qiao J
    Free Radic Biol Med; 2015 Sep; 86():295-307. PubMed ID: 26057937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome.
    Haouzi D; Assou S; Monzo C; Vincens C; Dechaud H; Hamamah S
    Hum Reprod; 2012 Dec; 27(12):3523-30. PubMed ID: 22951915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does polycystic ovary syndrome start in childhood?
    Diamanti-Kandarakis E; Christakou C; Palioura E; Kandaraki E; Livadas S
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):904-11. PubMed ID: 18552753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-Müllerian hormone and ovarian dysfunction.
    Broekmans FJ; Visser JA; Laven JS; Broer SL; Themmen AP; Fauser BC
    Trends Endocrinol Metab; 2008 Nov; 19(9):340-7. PubMed ID: 18805020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
    Dunaif A
    Endocr Rev; 1997 Dec; 18(6):774-800. PubMed ID: 9408743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of Notch signalling in ovarian angiogenesis.
    Xie Q; Cheng Z; Chen X; Lobe CG; Liu J
    J Ovarian Res; 2017 Mar; 10(1):13. PubMed ID: 28284219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polycystic ovarian disease: animal models.
    Mahajan DK
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):705-32. PubMed ID: 2973982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical review: Identifying children at risk for polycystic ovary syndrome.
    Rosenfield RL
    J Clin Endocrinol Metab; 2007 Mar; 92(3):787-96. PubMed ID: 17179197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?
    Baillargeon JP; Nestler JE
    J Clin Endocrinol Metab; 2006 Jan; 91(1):22-4. PubMed ID: 16263814
    [No Abstract]   [Full Text] [Related]  

  • 51. Altered microRNAs expression profiling in cumulus cells from patients with polycystic ovary syndrome.
    Liu S; Zhang X; Shi C; Lin J; Chen G; Wu B; Wu L; Shi H; Yuan Y; Zhou W; Sun Z; Dong X; Wang J
    J Transl Med; 2015 Jul; 13():238. PubMed ID: 26198660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome.
    Mukherjee S; Maitra A
    Indian J Med Res; 2010 Jun; 131():743-60. PubMed ID: 20571162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Polycystic ovary syndrome: from physiopathology to therapy].
    Vicino M; Loizzi V; Scardigno D; Selvaggi L
    Minerva Ginecol; 2006 Feb; 58(1):55-67. PubMed ID: 16498371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis of adolescent polycystic ovary syndrome.
    Hardy TS; Norman RJ
    Steroids; 2013 Aug; 78(8):751-4. PubMed ID: 23624032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Polycystic ovary syndrome: physiopathology review].
    Fux Otta C; Fiol de Cuneo M; Szafryk de Mereshian P
    Rev Fac Cien Med Univ Nac Cordoba; 2013; 70(1):27-30. PubMed ID: 23920100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of stress and sympathetic innervation in the development of polycystic ovary syndrome.
    Greiner M; Paredes A; Araya V; Lara HE
    Endocrine; 2005 Dec; 28(3):319-24. PubMed ID: 16388122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polycystic ovary syndrome and its developmental origins.
    Dumesic DA; Abbott DH; Padmanabhan V
    Rev Endocr Metab Disord; 2007 Jun; 8(2):127-41. PubMed ID: 17659447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased protein expression of LHCG receptor and 17α-hydroxylase/17-20-lyase in human polycystic ovaries.
    Comim FV; Teerds K; Hardy K; Franks S
    Hum Reprod; 2013 Nov; 28(11):3086-92. PubMed ID: 24014605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Polycystic ovary syndrome: A model of follicular excess].
    Robin G; Catteau-Jonard S; Dewailly D; Decanter C
    Gynecol Obstet Fertil; 2010 Jun; 38(6):405-8. PubMed ID: 20576552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proliferation and apoptosis in ovarian stromal hyperplasia and hyperthecosis.
    Sharabidze N; Sabakhtarashvili M; Burkadze G
    Georgian Med News; 2005 Dec; (129):26-9. PubMed ID: 16444023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.